Stryker expands imaging portfolio with acquisition of fluorescence firm

William Doss | | Radiology Business | Economics

Stryker Corporation has announced an agreement to acquire NOVADAQ Technologies, a firm specializing in fluorescence imaging technology used in surgery. The $701 million definitive agreement between Stryker and the Greater Toronto-based Novadaq is expected to close at the end of the third quarter.

NOVADAQ’s flagship SPY fluorescence imaging allows physicians to precisely visualize blood flow in vessels and tissue perfusion during treatment, reducing post-procedure complication rates and the cost of care. A minimally invasive companion product called PINPOINT offers similar features in an endoscopic package.

"I am proud of the impact our SPY and PINPOINT technology has made throughout the world in breast reconstruction and colorectal surgery, as well as other minimally invasive applications, and look forward to the additional progress we can make as part of Stryker's organization,” said Rick Mangat, President and CEO of NOVADAQ

Stryker is pouncing on NOVADAQ’s low share price of $6.50, down 36% compared to last year. However, the deal prices all shares at $11.75, almost double the closing price on June 16.

The cross-border transaction is subject to approval by NOVADAQ shareholders and Canadian regulatory bodies including the Ontario Superior Court of Justice.

"This acquisition aligns with Stryker's focus on enabling our customers to see and do more by enhancing cross-specialty surgical visualization," stated Timothy J. Scannell, Group President, MedSurg and NeuroTechnology. "NOVADAQ'S unique innovative technology complements Stryker's advanced imaging portfolio and expands our product offerings into open and plastic reconstructive surgery. NOVADAQ'S innovative technology can reduce post-procedure complication rates and the cost of care for a broad variety of surgical treatments."

William Doss

As a Senior Writer for TriMed Media Group, Will covers radiology practice improvement, policy, and finance. He lives in Chicago and holds a bachelor’s degree in Life Science Communication and Global Health from the University of Wisconsin-Madison. He previously worked as a media specialist for the UW School of Medicine and Public Health. Outside of work you might see him at one of the many live music venues in Chicago or walking his dog Holly around Lakeview.

Related Content

Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers
Congress ditches doc fix in stopgap end-of-year funding bill
Teleradiology provider inks post-acute care deal worth $1.5M annually
US Radiology Specialists affiliate expands into new market
Radiologist rails against insurer’s refusal to cover key interventional service
Blue Cross Blue Shield affiliate rejects MRI contrast coverage, labeling it ‘investigational’

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.